United Arab Emirates: First leukemia patient treated with CAR-T cell therapy starts football match – News
[ad_1]
The UAE Pro League extended a special invitation to Murad to start the match in Abu Dhabi
To commemorate the success of young Murad’s treatment for leukemia using the UAE’s first CAR-T cell therapy at the Abu Dhabi Stem Cell Center (ADSCC), the UAE Pro League extended a special invitation to Murad to start the match between the Al Wahda and Hatta football teams. on September 24, at the Al Nahyan Stadium in Abu Dhabi.
This initiative, organized in coordination between the UAE Pro League, the Abu Dhabi Stem Cell Center and the Abu Dhabi Department of Health, highlights the power of innovation and collaboration in the pursuit of better health and well-being, celebrating the successful treatment of the young man. .
This compassionate outreach demonstrates support for Murad and his family, highlights a commitment to helping young warriors like him, and signifies a broader mission to support all children fighting leukemia.
ADSCC’s manufacturing of CAR-T cells, a genetically engineered immune cell therapy, represents a groundbreaking advancement in the field of precision immunotherapy in the UAE. It allows precise targeting of cancer cells in people with specific types of blood cancers.
This remarkable medical achievement, initiated by the Abu Dhabi Stem Cell Centre, where doctors, experts, scientists and researchers always strive to deliver the latest medical innovations and treatments, solidifies the Centre’s position as a leader in research and development within the sector. Of the health. and further establishes Abu Dhabi as a global hub for healthcare and life sciences.
[ad_2]
